Ms Phoenix has more than 24 years of executive and commercial experience in pharmaceutical, veterinary and capital markets sectors, including holding operational and marketing roles at Pfizer, Novartis and Zoetis.

With a successful track record of product development, registration and marketing launches, including successful commercialisation of numerous market leading blockbuster medicines.

Karinza has served on the Myopharm Board of Directors for 4 years and has invested in almost all capital raises to date, while focussing on expanding Myopharm’s clinical and commercial initiatives.